Control n = 17 | Brain injury n = 11 | Sepsisa n = 38 (63% septic shock) | |
---|---|---|---|
Age (years) | 48 (34–59) | 58 (41–66) | 64 (54–79) |
Sexe (female) | 12 (70%) | 2 (18%) | 16 (46%) |
Charlson | 1 (0–2) | 2 (1–4) | 3 (2–6) |
Hypertension | 0 | 6 (55%) | 11 (29%) |
Reason for admission | NA | Traumatic 8 (73%) | Abdominal 14 (37%) |
Hemorrhagic stroke 3 (27%) | Pulmonary 10 (27%) | ||
Skin 7 (18%) | |||
Other 7 (18%) | |||
SAPS II at admission | NA | 49 (42–66) | 53 (38–64) |
SOFA at inclusion | NA | 7 (3–9) | 6 (4–11) |
Day of FLb | NA | 0.5 (0–1) | 1 (0–3) |
MAP (mmHg) | 74 (65–89) | 89 (77–96) | 67 (56–75) |
PaCO2 (mmHg) | NA | 38 (35–42) | 39 (36–42) |
ETCO2 (mmHg) | NA | 34 (30–36) | 33 (27–35) |
Natremia (mmol l−1) | NA | 138 (133–141) | 141 (138–144) |
Glycemia (mmol l−1) | NA | 6.8 (6.8–9.6) | 7.3 (5.8–8.6) |
Temperature (°C) | NA | 37 (37.2–38.0) | 37 (36.5–38) |
Propofol | 17 (100%) | 11 (100%) | 38 (100%) |
Midazolam | 0 | 7 (64%) | 11 (29%) |
Ketamine | 0 | 0 | 8 (21%) |
Fentanyl | 0 | 9 (82%) | 20 (53%) |
Norepinephrine | 0 | 7 (64%)c | 24 (63%)d |
Epinephrine | 0 | 0 | 2 (5%)e |